Position in PFE
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$88,558,509
-$6,022,764 QoQ
Shares Held
3,677,679
+9.2% QoQ
Ownership
0.065%
of shares outstanding
% of Portfolio
0.18%
of 13F equity value
Holder Rank
#109
of 2,837 holders
Holding Since
Mar 2024
9 quarters on record
Voting authority
Sole 92%
Shared 0%
None 8%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026DANSKE BANK A/S holds $2,497,183,706 across 11 Drug Manufacturers - General names. PFE ranks #7 (3.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
767,326 | $920,353,900 | |
| 2 | JNJ |
Johnson & Johnson
|
2,075,218 | $527,043,114 | |
| 3 | ABBV |
AbbVie Inc.
|
1,316,850 | $331,372,132 | |
| 4 | MRK |
Merck & Co., Inc.
|
2,152,022 | $276,534,826 | |
| 5 | AMGN |
Amgen Inc
|
404,031 | $146,307,704 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
840,400 | $106,176,134 | |
| 7 | PFE |
Pfizer Inc
This page
|
3,677,679 | $88,558,509 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
1,501,133 | $86,495,282 |
All Filings in PFE
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $88,558,509 | 3,677,679 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $94,581,273 | 3,368,279 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $85,156,779 | 3,419,951 | Shares | Sole | 2026-02-02 | |
| 2025-06-30 | $102,683,668 | 4,236,125 | Shares | Sole | 2025-12-18 | |
| 2025-03-31 | $93,743,073 | 3,699,411 | Shares | Sole | 2025-12-18 | |
| 2024-12-31 | $85,003,259 | 3,204,043 | Shares | Sole | 2026-03-18 | |
| 2024-09-30 | $107,623,315 | 3,718,843 | Shares | Sole | 2026-03-18 | |
| 2024-06-30 | $77,628,551 | 2,774,430 | Shares | Sole | 2026-03-18 | |
| 2024-03-31 | $74,392,977 | 2,680,828 | Shares | Sole | 2026-03-18 | |
| No filing history on record for this holder in this stock. | ||||||